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The impact of patient age and aortic size on the
results of aortobifemoral bypass grafting
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Anthony D. Whittemore, MD, and Michael Belkin, MD, Boston, Mass
Objectives: On the basis of the widespread belief that aortobifemoral bypass (ABF) represents the optimal mode of
revascularization for patients with diffuse aortoiliac disease, vascular surgeons are often aggressive about its application
in young adults. We undertook this retrospective evaluation of ABFs performed from 1980 to 1999 to determine whether
the results justify this approach. Patients of less than 50 years of age (n  45) were compared with those aged 50 to 59
years (n  93) and those aged more than 60 years (n  146).
Results: Younger patients were more likely to undergo operation for claudication than were older patients (72% versus
59% and 55%; P < .04). Younger patients were significantly more likely to be smokers (87%) but less likely to have
diabetes, hypertension, or cerebrovascular disease. Bypasses were constructed in an end-to-end fashion in 71.1% of
patients of less than 50 years versus 68.8% and 71.2% of older patients (P not significant). The mean diameter of aortic
grafts was significantly smaller in younger patients (14.6 mm) than in older patients (15.6 mm and 15.5 mm; P < .01).
The need for a subsequent infrainguinal reconstruction was highest in the youngest patients (24% versus 17% and 7%; P <
.01). Surgical mortality rates were low in all groups (0%, 1%, and 2.0% for increasing age groups; P  not significant).
Five-year primary and secondary patency rates increased significantly with each increase in age interval: 5-year primary
patency rate: less than 50 years, 66%  8%; 50 to 59 years, 87%  5%; more than 60 years, 96% 2% (P < .05 for all
comparisons). Five-year secondary patency rates were: less than 50 years, 79% 7%; 50 to 59 years, 91% 4%; more than
60 years, 98% 2% (P < .05 for all comparisons). Five-year survival rate was comparable in all three groups: less than 50
years, 93%  5%; 50 to 59 years, 92%  4%; more than 60 years, 87%  4% (P  not significant).
Conclusion: Increased virulence of aortic disease, smaller aortic size, and more progressive infrainguinal disease may all
negatively impact the results of ABF in younger patients. Although 5-year results are acceptable, increased caution is
warranted in the routine application of ABF in young patients without limb-threatening ischemia. (J Vasc Surg 2003;37:
1219-25.)
Premature atherosclerotic disease of the lower extrem-
ities in the young adult before age 50 years has been
associated with rapid progression of disease and a higher
incidence rate of graft occlusion.1-3 Aortobifemoral bypass
(ABF) has long been thought to represent the optimal
mode of revascularization for patients with diffuse aor-
toiliac disease; thus, vascular surgeons are often aggressive
about its application in young adults. We undertook this
retrospective evaluation of ABFs performed from 1980 to
1999 to determine whether the results justify this approach.
PATIENTS AND METHODS
A retrospective evaluation was performed on all ABF
grafts done consecutively at the Brigham and Women’s
Hospital between January 1980 and December 1999. Data
were retrieved from a computerized registry in which de-
mographics, risk factors, procedure variables, and fol-
low-up information have been prospectively entered for all
vascular surgery patients at our institution since 1975. A
detailed review of computerized inpatient records, office
charts, operative reports, vascular laboratory reports, and
angiographic findings was performed.
Aortic graft size was selected to optimize the size match
with the native vessels and used as a surrogate for actual
aortic diameter, which was not measured. The type of
proximal anastomosis (end-to-end versus end-to-side) was
determined by the surgeon on the basis of occlusive exter-
nal iliac disease or a wish to avoid sacrificing a large patent
inferior mesenteric artery. The distal anastomosis was con-
structed to the common femoral artery when both angio-
graphic and intraoperative assessment deemed the superfi-
cial femoral and profunda femoris arteries to be widely
patent. If this was not the case, the anastomosis was carried
onto the profunda femoris artery. Typical postoperative
care included short-term monitoring in the surgical inten-
sive care unit with  blockade and aspirin.
Follow-up examinations occurred within the first
month of surgery, then at 3-month intervals during the first
year, followed annually thereafter. Patency was easily con-
firmed with the presence of palpable femoral pulses and,
when necessary, appropriate vascular laboratory studies. A
return of symptoms or change in physical examination
prompted further work-up, leading to intervention when
appropriate.
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Limb salvage was defined as freedom from major am-
putation. Primary patency (PP) and secondary patency (SP)
were defined in accordance with the suggested reporting
standards of the Ad Hoc committee of the Society for
Vascular Surgery and the North American Chapter of the
International Society for Cardiovascular Surgery.4 Survival,
graft patency, and limb salvage rates were calculated with
the life-table method. Failures were defined as an occluded
graft as determined with arteriography or with loss of
palpable femoral pulses. Limb salvage rates were assessed
only in those patients who underwent operation for limb
salvage. Standard errors were calculated with the Green-
wood method, and comparisons were made between
groups with the Mantel-Cox log-rank analysis. Categoric
variables listed in Table I were compared with 2 analysis. A
P value of less than .05 was considered to represent statis-
tical significance. Cox proportional hazards regression
methods were used to model the relationship between graft
occlusion and the covariates described in Table I. As there
were only a limited number of graft failures, conventional
multivariate analysis could not be applied because, in gen-
eral, discrete data analysis suggests that only one variable
for every 10 to 15 cases evaluated should be analyzed5 (ie,
if only 20 occlusions were noted in a data set, sufficient
power existed for testing two variables at the most). Addi-
tional matched analyses were performed to eliminate con-
founding variables. Length of follow-up data was analyzed
with Student two-tailed t test. Patients were censored if
they died or were lost to follow-up or at the termination of
the study. Lost to follow-up was defined as the last patient
visit or contact being more than 18 months before the
completion of the study at the end of 1999.
RESULTS
During the 20-year period, 284 ABF grafts were per-
formed in 281 patients. One hundred twenty-seven (45%)
were completed in the 1980s, and 157 (56%) in the 1990s.
Forty-five patients were less than 50 years old, 93 patients
were 50 to 59 years old, and 146 patients were more than
60 years of age. There were 165 men and 119 women, with
51% of the patients under the age of 50 years comprised of
women. Risk factors included smoking (79%), hyperten-
sion (55%), and coronary artery disease (46%), with 13% of
patients having undergone previous coronary artery bypass
grafting (Table I). Younger patients of less than 50 years of
age were significantly more likely to be active or former
smokers when compared with those who were more than
60 years old (87% versus 64%, respectively; P  .002) but
were less likely to have diabetes, hypertension, or cerebro-
vascular disease or to undergo operation for limb salvage
(P  .05 for all comparisons), as shown in Table II. There
were significantly more women in the group of less than 50
years old compared with the 50 to 59 year olds, but no
difference was noted when compared with those more than
60 years (Table II).
Overall, 59% of aortobifemoral reconstructions were
performed for claudication and 41% for limb salvage (rest
pain, 26%; ulcer, 11%; gangrene, 4%), with significantly
more patients undergoing operation for limb salvage in the
older age group compared with the younger age group
(Table II). Fifteen percent of all patients had undergone
previous inflow procedures, with significantly more in those
Table I. Characteristics of study population (n  281)
Variable Percent
Mean
(SD)
Patient characteristics
Age 60.1 (9.4)
50 y 14.6%
50-59 y 33.5%
60 y 51.4%
Gender (male) 58.0%
Smoker 71.5%
History of diabetes 20.6%
History of hypertension 55.2%
History of coronary artery disease 46.3%
History of CABG 12.8%
History of cerebrovascular disease 6.8%
History of COPD 17.8%
History of chronic renal insufficiency 3.2%
History of congestive heart failure 6.4%
Procedure characteristics
Decade of procedure (1990s) 54.8%
Graft size (mm) 15.4 (1.6)
Indication (claudication versus salvage) 59.1%
Runoff
Common femoral artery 88.2%
Profunda femoral artery 7.9%
Proximal superficial femoral artery 3.9%
Type of anastomosis
End-end 70.0%
End-side 30.0%
Subsequent outflow procedure
performed
13.5%
SD, Standard deviation; CABG, coronary artery bypass grafting; COPD,
chronic obstructive pulmonary disease.
Table II. Characteristics of study population by age
group
Risk factors 50 y 50-59 y 60 y
Smoking 39 (87%)* 72 (77%)* 93 (64%)
Male gender 22 (49%)† 66 (71%)* 77 (53%)
Female gender 23 (51%)† 27 (29%)* 69 (47%)
Hypertension 16 (36%)* 46 (49%)* 93 (64%)
Coronary artery disease 26 (58%) 39 (42%) 67 (46%)
Prior CABG 5 (11%) 9 (10%) 21 (14%)
Diabetes 4 (9%)* 23 (25%) 32 (22%)
Chronic pulmonary disease 8 (18%) 10 (11%)* 33 (23%)
Cerebrovascular disease 0 (0%)* 6 (6%) 13 (9%)
Chronic renal disease 0 (0%) 4 (4%) 5 (3%)
Claudication 32 (71%)* 55 (59%) 80 (55%)
Limb salvage 13 (29%)* 38 (41%) 66 (45%)
Previous inflow procedure 10 (22%)* 18 (19%)* 13 (9%)
Iliac angioplasty 6 (13%)* 9 (10%)* 5 (3%)
ABF 5 (11%) 4 (4%) 5 (3%)
All P values not significant except where noted.
*P  .05 when compared with 60 years group.
†P  .05 when compared with 50 to 59 years group.
CABG, Coronary artery bypass grafting.
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less than 50 years and 50 to 59 years compared with those
more than 60 years (Table II). Of the previous inflow
procedures performed, a significantly higher number of
iliac angioplasties were done in both the less than 50 years
and 50 to 59 years age groups when compared with patients
more than 60 years, with no appreciable difference when
considering prior ABF bypass grafts (Table II). Six percent
of patients had previous infrainguinal reconstruction (P 
not significant for all age groups).
Graft material consisted of woven or knitted polyester
in 44% of patients, collagen-coated Dacron grafts in 55%,
and polytetrafluoroethylene in 1%. Seventy percent of pa-
tients had the proximal anastomosis constructed in an
end-to-end fashion, with 30% end-to-side (P  not signif-
icant for all age groups). The mean graft diameter was
significantly smaller in younger patients compared with
those more than 50 years old (14.6 mm versus 15.6 and
15.5 mm; P .01). The distal anastomosis was constructed
to the common femoral artery with and without extension
onto the profunda femoris in 88% of patients (50 years,
86%; 50 to 59 years, 92%; 60 years, 86%), the profunda
femoris in 8% (50 years, 11%; 50 to 59 years, 6.5%; 60
years, 11%), and the proximal superficial femoral artery in
4% (50 years, 3%; 50 to 59 years, 6%;60 years, 3%), with
no significant difference between age groups (P .5 for all
comparisons).
The overall postoperative morbidity rate was 32%, in-
cluding cardiac complications (15%: arrhythmia, 12%; myo-
cardial infarction, 2%; congestive heart failure, 1%), gastro-
intestinal problems (8%: prolonged ileus, 5%; ischemic
colon, 1%; gastrointestinal bleed, 1%; hepatic failure, 1%),
wound infections (3.5%), and renal failure (3.2%). Major
morbidity (myocardial infarction, stroke, and renal and
pulmonary failure) occurred in 9%. Early (30 days) graft
failure occurred in four patients (1%; two patients 50
years old, 2%; two patients 50 to 59 years old, 2%; 0 patients
60 years old). No significant difference was noted be-
tween the three age groups in postoperative morbidity or
mortality rates; however, the less than 50 years and 50 to 59
years groups were more likely to have early graft failure
when compared with the more than 60 years group (50
years, 2%; 50 to 59 years, 2%; 60 years, 0; P  .05 when
50 and 50 to 59 years compared with  60 years).
Overall, the 30-day operative mortality rate of 1% (50
years, 0 patients; 50 to 59 years, 1 patient; 59 years, 3
patients) was from congestive heart failure, myocardial
infarction, respiratory failure, and multisystem organ fail-
ure, with no significant difference between age groups. The
mean follow-up period was 48 months (range, 1 to 236
months), with a significantly longer follow-up period in the
younger age group (mean, 65 months) compared with the
more than 60 years group (mean, 45 months; P  .016).
One hundred twelve patients (39%) were lost to follow-up.
The overall 5-year cumulative PP rate was 85%  3%,
with a SP rate of 92% 2% (Table III). No difference in the
overall 5-year cumulative PP rate was noted when compar-
ing claudication versus limb salvage (Fig 1) as an indication
for operation nor in comparing PP rate in male versus
female (Fig 2) subgroups (Table III). There was also no
significant difference in overall 5-year cumulative PP rate
when comparing end-to-end versus end-to-side configura-
tion of the proximal anastomosis (Fig 3; Table III). The PP
rate improved progressively with each age group (Fig 4),
with a 5-year cumulative PP rate of 66%  8% in the less
than 50 years group compared with 87% 5% in the 50 to
Table III. Life-table analysis of ABF grafts
Characteristics
or indication
for surgery 5-y PP rate 5-y SP rate
Overall 85.0%  2.6% 92.5%  2.2%
P value NA NA
Claudication 87.7%  3.4% 91.7%  2.9%
Limb salvage 88.7%  3.8% 93.7%  3.1%
P value .421 .319
Male gender 89.7%  3.4% 94.8%  2.6%
Female gender 86.6%  3.8% 90.6%  3.5%
P value .271 .169
50 y 65.7%  8.4% 79.2%  7.2%
50-59 y 87.3%  4.8% 91.4%  4.2%
60 y 97.5%  1.7% 98.8%  1.2%
P value * *
End-to-end 89.1%  3.0% 93.4%  2.5%
End-to-side 85.8%  4.7% 92.3%  3.7%
P value .278 .401
*P  .05 for all comparisons.
NA, Not applicable.
Fig 1. Life-table analysis of cumulative PP rates for ABF grafts
according to indication.
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59 years group and 96%  2% in the more than 60 years
group (P  .05 for all comparisons). A similar improve-
ment in progression in SP rate was also noted between age
groups, with a 5-year cumulative SP rate of 79% 7% in the
less than 50 years group, 91%  4% in the 50 to 59 years
group, and 99%  1% in those more than 60 years (Table
III). The 5-year cumulative survival rates were 93%  5%,
92%  4%, and 87%  4%, respectively, in the increasing
age groups (P  not significant). The younger age group
was more likely to require subsequent infrainguinal recon-
struction in the follow-up period (24%) when compared
with the older age group (7%; P  .001).
In a univariate analysis evaluating variables predictive of
graft failure, age (P  .0001), aortic size (P  .0004), and
hypertension (P  .04) were found to be significant vari-
ables (Table IV). Conditional logistic regression analysis
then was used to analyze age-matched case controls to
eliminate the potential confounding effect of age on the
other significant variables of interest (Table V). When
correcting for patient age, aortic graft size remained a
significant predictor of graft occlusion (risk ratio, 0.7/mm
graft size; P  .03), showing that larger graft size had a
significant protective effect, independent of age. When
adjusted for graft size, age remained highly significant (risk
ratio, 0.9/y; P .002), suggesting a 10% risk reduction of
graft occlusion for every 1-year increase in age, indepen-
dent of graft size.
DISCUSSION
Symptomatic atherosclerosis in young adults has been
reported in the literature as a poor prognostic finding
because of multiple vascular bed involvement and the ac-
celerated nature of the disease process.6-9 Other investiga-
tors have noted, however, that younger patients have more
localized aortic atherosclerosis.10 Our study directly com-
pared 45 patients of less than 50 years of age with groups
Fig 2. Life-table analysis of cumulative PP rates for ABF grafts
according to gender.
Fig 3. Life-table analysis of cumulative PP rates for ABF grafts
according to proximal anastomosis configuration.
Fig 4. Life-table analysis of cumulative PP rates for ABF grafts
according to age.
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from 50 to 59 years of age (n  93) and of more than 60
years of age (n 146) and found that younger patients had
significantly inferior patency rates, with a 66% 5-year cumu-
lative PP rate compared with 96% in the older age group
(P  .05). We determined that age and aortic size were
important predictors for graft failure. We did not appreciate
differences in patency when looking at construction of the
proximal anastomosis or gender.
Our findings of inferior long-term patency in young
adults are consistent with those of Valentine et al,11 who
reported a 65% 3-year cumulative graft patency rate, and
Olsen and colleagues,3 who found 34% of younger patients
needed further intervention to maintain long-term patency
after ABF bypass. Why patients with premature atheroscle-
rosis are prone to failure after revascularization is not clear.
Perhaps a more virulent form of atherosclerosis or even
more aggressive intimal hyperplasia exists in this age group.
A significantly higher number of our younger patients had
undergone previous inflow procedures when compared
with the older age group. Although the multivariate anal-
ysis did not prove this to be a predictor of future graft
failure in the less than 50-year-old patient, it could be a
marker of virulent atherosclerotic disease that may account
for poor patency rates. It may also suggest multisegmental
disease in young patients—a point that remains controver-
sial in the literature.12 We did find that younger patients
had a significantly higher rate of subsequent infrainguinal
reconstruction when compared with the older age group;
however, this may be in part from a longer period of
follow-up.
Our analysis also revealed that patients with smaller
aortas had poorer long-term patency rates, consistent with
findings by Valentine et al11 and others.13,14 Others have
reported that graft size, our surrogate for aortic diameter, is
not a factor. Schneider et al15 found no difference in 3-year
SP rate between patients with small diameter grafts versus
those with larger diameters. Although we found small
aortic graft size to be a risk factor for occlusion, it is unclear
whether small aortic size, small graft size, or perhaps both
are contributors to the lower patency rates. We hypothesize
that a smaller aorta may be less accommodating to intimal
hyperplasia or perhaps result in a lower threshold for
thrombosis. This may also hold true in the periphery where
patients with smaller aortas likely have smaller outflow
vessels in the groin more prone to hemodynamic compro-
mise. Although we did not measure the size of the distal
arteries in our retrospective study, others have done so and
found a close association between small aortic size and
small peripheral arteries.10
We did not find gender to be a risk factor for graft
occlusion, in keeping with the findings of Valentine et al,11
who found the size of the infrarenal aortic segment the
critical determinant of late graft patency, regardless of
gender. Similarly, Schneider et al15 noted a 92% 3-year
patency rate in women versus 82% in men (P  .53). We
also found no difference in patency related to the configu-
ration of the proximal anastomosis, which is consistent with
findings of others.11,15
Considering the relatively poor patency rates of ABF
grafting in young patients and those with smaller aortas, it
is important to consider the therapeutic options. For those
patients with claudication, risk factor modification, exer-
cise, and pharmacologic therapy are options. A formal
exercise-training program remains the primary nonpharma-
cologic treatment for claudication, as shown in more than
20 randomized trials.16 Placebo-controlled studies com-
paring phosphodiesterase type 3 inhibitors, such as cilosta-
zol, with pentoxifylline showed an improvement in walking
distance by 40% to 50% with cilostazol.17 Many young
adults who are employed and otherwise active seek a more
definitive (if not permanent) treatment for their disability.
Aortoiliac angioplasty, with or without stenting, is the
preferred treatment for patients with segmental aortoiliac
disease. Patients with severe multifocal disease and occlu-
Table IV. Crude relationships between potential
predictors and graft occlusion
Variable
Relative
risk ratio
for failure 95% CI P value
Patient characteristics
Age* 0.91 (0.87, 0.95) .0001
Gender (male) 0.71 (0.30, 1.68) .4373
Smoker 3.63 (0.84, 15.57) .0833
History of diabetes 0.34 (0.08, 1.48) .1509
History of hypertension 0.37 (0.14, 0.94) .0373
History of coronary artery
disease
0.52 (0.21, 1.29) .1565
History of COPD 0.43 (0.10, 1.86) .2613
Procedure characteristics
Decade of procedure (1990s) 0.55 (0.22, 1.36) .1948
Graft size (mm)† 0.56 (0.41, 0.77) .0004
Indication (claudication
versus salvage)
1.55 (0.62, 3.83) .3475
Type of anastomosis
(end-side versus end-end)
1.39 (0.44, 4.37) .5793
Subsequent outflow procedure
performed
1.70 (0.66, 4.43) .2748
*Relative risk ratio for failure is for 1-y increase in age.
†Relative risk ratio for failure is for 1-mm increase in graft size.
COPD, Chronic obstructive pulmonary disease.
Table V. Age-adjusted relationships between predictors
with crude P values .20 and graft occlusion
Variable
Age-adjusted
rate ratio 95% CI P value
Patient characteristics
Smoker 2.09 (0.47, 9.30) .3331
History of diabetes 0.40 (0.09, 1.74) .2242
History of hypertension 0.52 (0.20, 1.37) .1868
History of coronary artery
disease
0.47 (0.19, 1.16) .0998
Procedure characteristics
Decade of procedure (1990s
versus 1980s)
0.79 (0.31, 2.03) .6188
Graft size* 0.70 (0.50, 0.96) .0281
*Adjusted rate ratio for a 1 millimeter increase in graft size.
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sions (TransAtlantic Inter-Society Consensus C and D
patients18) are generally considered better candidates for
surgical reconstruction. Nonetheless, reasonable results
have been reported with aggressive applications of endo-
vascular therapy in these patients.19,20 Powell et al21 found
acceptable primary assisted patency rates of 72% at 3 years
with a reintervention rate of 29% at a mean time of 10  3
months in patients undergoing angioplasty and stenting of
multisegment iliac occlusive disease. Their work revealed
inferior patency rates in patients with external iliac disease,
although neither of the groups was stratified according to
age. Whenever feasible, it seems appropriate to attempt
endovascular therapy in younger patients as the first line of
intervention.
An important factor, not addressed in this retrospective
study, is the functional outcome of ABF grafting in young
adults. Although the bias of most vascular surgeons is that
the quality of life of most patients is dramatically improved
with ABF grafting, the findings in the literature have not
been consistent. With a five-point questionnaire, Zannetti,
L’Italien, and Cambria22 found optimal functional results
could be obtained in nondiabetic patients less than 70 years
old operated on for intermittent claudication. They found
most negative functional results came from those patients
who had undergone infrainguinal reconstruction and were
bothered by long-term lower extremity swelling. Schneider
et al23 retrospectively questioned 60 patients who had
undergone ABF grafting and found that despite normaliza-
tion of hemodynamics, the functional result was seriously
limited by the patients’ reported decrement in role func-
tion, health perception, and increased bodily pain after
surgery. Although the average age in Schneider et al’s21
study was 61  1 years, such diminished perceptions may
be less prevalent in younger patients. It is reasonable to
speculate that the functional and quality of life benefits in
younger patients may be greater than in older, more debil-
itated patients.
As a retrospective study collected over two decades, this
study has certain limitations. Endovascular therapy has
evolved significantly during this interval, and some of the
patients treated with aortobifemoral grafting early on in
this series would now be treated with angioplasty with or
without stenting. As mentioned previously, a complete
evaluation of the utility of aortobifemoral surgery, particu-
larly in young adults, would require a quality-of-life assess-
ment. This is an important area for future investigation.
Finally, the 39% rate lost to follow-up in this series merits
some comment. In our experience, the rate lost to fol-
low-up among ABF patients is among the highest of all the
patients we treat. We believe this largely reflects the defin-
itive and excellent results of this operation. Patients who are
relieved of their symptoms and continue to do well gradu-
ally begin to space out return visits to beyond 18 months
(the definition of lost to follow-up) only to return if prob-
lems arise.
The findings of this study thus pose a dilemma for
vascular surgeons. ABF grafting has long been considered
to be one of our most effective and durable vascular recon-
structions. It has therefore been widely applied and would
seem ideally suited for application in younger patients in
whom a durable result is more desirable. The results of ABF
in young adults in this series are certainly acceptable and
offer appropriately selected patients greater potential ben-
efit. These results, however, clearly show inferior patency
rates and the need for subsequent interventions in younger
patients. The potential impact of graft failure and the need
for subsequent complex interventions must be consid-
ered—particularly in younger patients with a longer life
expectancy. Exhaustion of all noninterventional and perti-
nent endovascular options is the appropriate first line op-
tion for young patients with severe aortoiliac occlusive
disease.
We thank Ms Julie Lombara for assistance in data
preparation.
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